F3 and breast carcinoma: Tissue factor pathway inhibitor (TFPI) is an endogenous inhibitor of tissue factor-induced blood coagulation, and its expression has been demonstrated in smooth muscle cells, monocytes, platelets, and several breast cancer cell lines [22–24].